The annual meeting of the American College of Gastroenterology was held from Oct. 24 to 29 in Phoenix, attracting participants from around the world, including gastroenterology and digestive disease ...

Novo Nordisk (NVO) and Eli Lilly (LLY) are nearing a deal with the White House on obesity drug pricing, with initial reports suggesting that the companies will price obesity drugs at $149 per month ...

Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

The three GLP-1 receptor agonist (RA) drugs liraglutide (Victoza), semaglutide (Ozempic), and dulaglutide (Trulicity) provided similar cardiovascular and kidney benefits in people with type 2 diabetes ...

In the trial, 136 adults with overweight or obesity were randomly assigned to receive weekly injections of nimacimab, semaglutide, both drugs together, or placebo. Participants who received nimacimab ...

Semaglutide 7.2 mg, compared with semaglutide 2.4 mg and placebo, was associated with superior efficacy outcomes and comparable safety among patients with obesity. Use of semaglutide 7.2 mg vs 2.4 mg ...

Semaglutide or tirzepatide should be first-line drugs for obesity and most of its related complications, new guidance from the European Association for the Study of Obesity recommended. The authors of ...

New findings presented by Jörn Schattenberg at UEG Week 2025 in Berlin, Germany, demonstrate that semaglutide 2.4 mg provides significant improvements in metabolic dysfunction-associated ...

Researchers in one study found that semaglutide may indirectly improve adherence to antipsychotic therapy for those with schizophrenia and lower expensive acute episodes by preventing weight gain and ...

Estimated mean change in body weight from baseline to week 64 was −13.6 and −2.2% with oral semaglutide and placebo, respectively. HealthDay News — Oral semaglutide (25 mg) is effective for weight ...

Feasibility of implementing a virtual nursing-led smoking cessation clinic for patients with cancer. Absolute change in metabolic markers at 24 months between study groups.